https://orcid.org/0000-0002-6722-6966
About the Authors
- Maxime Golias
-
Roles Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Affiliations Excilone, Elancourt, France, Nantes Université, CNRS, UMR6286, US2B, Nantes, France, Institut de Cancérologie de l’Ouest, Tumor Heterogeneity and Precision Medicine Laboratory, Saint-Herblain, France
- Zuzana Krupova
-
Roles Conceptualization, Supervision, Validation, Writing – review & editing
Affiliation Excilone, Elancourt, France
- Pierre Defrenaix
-
Roles Funding acquisition, Project administration, Writing – review & editing
Affiliation Excilone, Elancourt, France
- Marie-Françoise Heymann
-
Roles Conceptualization, Methodology, Supervision, Validation, Writing – review & editing
* E-mail: dominique.heymann@univ-nantes.fr (DH); marie-francoise.heymann@ico.unicancer.fr (M-FH)
Affiliations Nantes Université, CNRS, UMR6286, US2B, Nantes, France, Institut de Cancérologie de l’Ouest, Tumor Heterogeneity and Precision Medicine Laboratory, Saint-Herblain, France
- Dominique Heymann
-
Roles Conceptualization, Funding acquisition, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: dominique.heymann@univ-nantes.fr (DH); marie-francoise.heymann@ico.unicancer.fr (M-FH)
Affiliations Nantes Université, CNRS, UMR6286, US2B, Nantes, France, Institut de Cancérologie de l’Ouest, Tumor Heterogeneity and Precision Medicine Laboratory, Saint-Herblain, France, Université of Sheffield, School of Medicine and Population Health, Sheffield, United Kingdom
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: ZK and MG are employees of Excilone, with MG being a PhD student. PD is the founder of Excilone and holds stock options.